Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
20. November 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
15. November 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
16. Mai 2024 06:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
13. März 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments
Arrival of Aurora’s Cannabis Material at Pharmacy Australia Centre of Excellence
29. März 2018 08:30 ET
|
PreveCeutical Medical Inc.
VANCOUVER, B.C., March 29, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces the arrival of the...
Biopolymer Films Market to exceed $6bn by 2024: Global Market Insights Inc.
15. März 2017 04:00 ET
|
Global Market Insights
Ocean View, Delaware, March 15, 2017 (GLOBE NEWSWIRE) -- The research report “Biopolymer Films Market Size By Raw Material (Bio-based, Microbial Synthesized, Synthetic, Partially Bio-based), By...